olaparib Tablets 100 mg, 150 mg
Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Manufacturer #18975
This contract development and manufacturing organization (CDMO) specializes in producing a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, tablets, and capsules. They cater to clients across the globe, with a strong presence in regions like the EU and North America. Their expertise spans several key therapy areas, utilizing various dosage forms such as oral solid dose. They prioritize quality assurance, adhering to strict GMP certifications and holding numerous product patents.
Manufacturer usually replies in 41 days
None